— Know what they know.
Not Investment Advice

ZBIO NASDAQ

Zenas BioPharma, Inc.
1W: +5.0% 1M: -1.1% 3M: -23.3% YTD: -42.5% 1Y: +72.8%
$18.97
-0.87 (-4.39%)
 
Weekly Expected Move ±11.6%
$14 $16 $18 $20 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 49 · $846.9M mcap · 10M float · 6.72% daily turnover · Short 54% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-100.0% YoY
$-425M
Net Income
-240.7% YoY
$-210M
Free Cash Flow
-97.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-153.3%
ROA-112.8%
ROIC1585.1%

Valuation

P/E-2.5
P/B3.1
EV/EBITDA-2.0

Leverage

Debt/Equity0.33
Current Ratio5.61
Interest Cov.-62.5x

Quality Scores

Piotroski F2/9
Altman Z-0.84
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms